What is OrthoLazer?
OrthoLazer Orthopedic Laser Centers specializes in providing FDA-cleared laser therapy, a non-invasive and drug-free approach to managing chronic and acute orthopedic pain. The company's innovative treatment aims to reduce pain and inflammation, accelerate natural healing processes, and support post-surgical recovery for a wide range of conditions affecting the knee, hip, shoulder, neck, back, foot, and elbow. OrthoLazer's commitment to patient well-being has positioned it as a trusted provider, recommended by health organizations and utilized by orthopedic specialists seeking effective, comfortable care solutions to improve patient quality of life.
How much funding has OrthoLazer raised?
OrthoLazer has raised a total of $7M across 1 funding round:
Series A
$7M
Series A (2024): $7M, investors not publicly disclosed
What's next for OrthoLazer?
The recent major strategic investment in OrthoLazer signals a pivotal growth phase for the company. This capital infusion is expected to fuel further expansion of its service offerings and market reach, potentially enabling the development of new therapeutic applications or the enhancement of existing laser therapy technologies. The company's focus on non-invasive, drug-free pain management aligns with growing healthcare trends, suggesting a strong trajectory for future development and increased adoption within the orthopedic and pain management industries.
See full OrthoLazer company page
